SUBSCRIBE
SUBSCRIBE

Indications

PRESS RELEASES
Press Releases
Quebec becomes first province in Canada to list new subcutaneous OPDIVO® on public drug plan for solid tumour indications
December 12, 2025
 · 
4 min read
Press Releases
Centessa Pharmaceuticals Announces CEO Transition as Company Advances Strategy to Extend Orexin Leadership into Multiple Neuroscience Indications
December 11, 2025
 · 
9 min read
Press Releases
Press Release: Sanofi’s Qfitlia and Cablivi approved in China, expanding care for rare diseases
December 11, 2025
 · 
11 min read
Press Releases
Intuitive Announces Expanded Indications for da Vinci SP
December 11, 2025
 · 
3 min read
Press Releases
Enveda Initiates Phase 2 Clinical Trials of ENV-294, a First-in-Class Oral Therapy in Atopic Dermatitis and Asthma
December 10, 2025
 · 
4 min read
Press Releases
SELLAS Life Sciences Presents Positive Phase 2 Data of SLS009 in Combination with AZA/VEN in Relapsed/Refractory AML-MR at ASH 2025
December 8, 2025
 · 
5 min read
Press Releases
All Approved Indications of Five Akeso’s Innovative Drugs Included in China’s Latest NRDL: Featuring Two First-in-Class Bispecifics with New First-Line Indications and Three Newly Negotiated Drugs
December 8, 2025
 · 
7 min read
Press Releases
Antengene Announces IND Approval in China for Phase Ib/II Study of ATG-022 (CLDN18.2 ADC) in Combination with KEYTRUDA® (Pembrolizumab) ± Chemotherapy
December 2, 2025
 · 
6 min read
Press Releases
Nyxoah’s Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule
November 26, 2025
 · 
5 min read
Press Releases
Vasomune Therapeutics Inc., and AnGes Inc., Expand the Scope of the Co-Development Agreement to Target Additional Indications
November 26, 2025
 · 
2 min read
Press Releases
Harmony Biosciences Announces Positive Results From the Pivotal Bioequivalence Study for Pitolisant Gastro-Resistant Formulation
November 24, 2025
 · 
12 min read
Press Releases
U.S. FDA Approves HYRNUO® (sevabertinib) for Previously Treated Patients with HER2-Mutated Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
November 21, 2025
 · 
10 min read
Press Releases
EYLEA HD® (aflibercept) Injection 8 mg Approved by FDA for the Treatment of Macular Edema Following Retinal Vein Occlusion (RVO) and for Monthly Dosing Across Approved Indications
November 20, 2025
 · 
15 min read
Press Releases
European Commission Approves Subcutaneous Administration of KEYTRUDA® (pembrolizumab) for All Adult Indications Approved in the European Union
November 19, 2025
 · 
19 min read
Press Releases
Piccolo Medical® Receives FDA Clearance to Expand ECGuide™ Technology Use to Pediatric and Neonatal Patients
November 18, 2025
 · 
2 min read
Press Releases
George Medicines presents long-term efficacy and safety data for single pill triple combination therapy for hypertension at American Heart Association’s Scientific Sessions 2025
November 10, 2025
 · 
8 min read
Press Releases
New Research Demonstrates the Advantages of an Insourced Dialysis Service Line for Acute-Care Facilities Using Outset Medical’s Tablo® Hemodialysis System
November 5, 2025
 · 
4 min read
Press Releases
Wandercraft Gains Second FDA Indication Extension for Atalante X in Less Than Two Years, Extending Advanced Robotic Rehabilitation for More Patients with Severe Mobility Loss
November 4, 2025
 · 
6 min read
Press Releases
U.S. FDA grants interchangeability designation to Celltrion’s denosumab biosimilars, STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo)
October 30, 2025
 · 
13 min read
Press Releases
OPKO Health’s ModeX Therapeutics Enters into Research Collaboration with Regeneron to Develop Multispecific Antibodies for Select Therapeutic Indications
October 30, 2025
 · 
6 min read
Load More